Our genes, our selves: hereditary breast cancer and biological citizenship in Norway. - PubMed - NCBI

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway. - PubMed - NCBI

Med Health Care Philos. 2016 Oct 5. [Epub ahead of print]

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

Solbrække KN1, Søiland H2,3, Lode K4, Gripsrud BH5.

Author information

Abstract

In this paper we explore the rise of 'the breast cancer gene' as a field of medical, cultural and personal knowledge. We address its significance in the Norwegian public health care system in relation to so-called biological citizenship in this particular national context. One of our main findings is that, despite its claims as a measure for health and disease prevention, gaining access to medical knowledge of BRCA 1/2 breast cancer gene mutations can also produce severe instability in the individuals and families affected. That is, although gene testing provides modern subjects with an opportunity to foresee their biological destiny and thereby become patients in waiting, it undoubtedly also comes with difficult existential dilemmas and choices, with implications that resonate beyond the individual and into different family and love relations. By elaborating on this finding we address the question of whether the empowerment slogan, which continues to be advocated through various health, BRCA and breast cancer discourses, reinforces a naïve or an idealized notion of the actively responsible patient: resourceful enough to seek out medical expertise and gain sufficient knowledge, on which to base informed decisions, thereby reducing the future risk of developing disease. In contrast to this ideal, our Norwegian informants tell a different story, in which there is no apparent heroic mastery of genetic fates, but rather a pragmatic attitude to dealing with a dire situation over which they have little control, despite having complied with medical advice through national guidelines and follow-up procedures for BRCA 1/2 carriers. In conclusion we claim that the sense of safety that gene testing and its associated medical solutions allegedly promise to provide proved illusory. Although BRCA-testing offers the potential for protection from adverse DNA-heritage, administered through possibilities for self-monitoring and self-management of the body, the feeling of 'being in good health' has hardly been reinforced by the emergence of gene technology.

KEYWORDS:

Biological citizenship; Gender; Genetic testing; Hereditary breast cancer; Norway; Subjectivity

PMID:

 

27709396

 

DOI:

 

10.1007/s11019-016-9737-y

[PubMed - as supplied by publisher]

Public Health Genomics Knowledge Base (v1.2)

BREAST CANCER

Last Updated: Oct 14, 2016

• Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
  Fjeldheim F N, et al. BMC cancer 2016 10 (1) 776
• Implementing Public Health Genomics in Your State: Resources from the CDC Office of Public Health Genomics
  Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States
• Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
  Solbrække Kari Nyheim et al. Medicine, health care, and philosophy 2016 Oct
• Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
  Cocca Massimiliano et al. Journal of translational medicine 2016 Jan 1422
• Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?
  McCormick G et al. Clinical oncology (Royal College of Radiologists (Great Britain)) 2016 Mar 28(3) 226
• The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.
  Amara Nabil et al. Familial cancer 2016 Jan 15(1) 1-17
• Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
  Geyer Felipe C, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 10
• TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
  Andrade Raissa Coelho, et al. Familial cancer 2016 10
• Upregulation of HSF1 in estrogen receptor positive breast cancer.
  Gökmen-Polar Yesim, et al. Oncotarget 2016 10
• Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
  Muranen Taru A, et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 10
• Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
  Mu Zhaomei, et al. International journal of molecular sciences 2016 9 (10)
• Relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and breast cancer chemotherapy response.
  Yang L, et al. Genetics and molecular research : GMR 2016 9 (3)
• The precision relationships between eight GWAS-identified genetic variants and breast cancer in a Chinese population.
  Chen Yazhen, et al. Oncotarget 2016 9
• Breast and Ovarian Cancer 
• FEN1 -69G>A and +4150G>T polymorphisms and breast cancer risk.
  Rezaei Maryam, et al. Biomedical reports 2016 10 (4) 455-460

• CDC Information (11)
• CDC-Authored Pub (12)

• Human (158)
• Pathogen (1)

• Human (5362)
• Pathogen (0)

• Human (483)
• Pathogen (0)

• Guidelines (23)
• Tier Table (19)
• Synthesis (53)

• Huamn (115)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB